![]()
|
Report Date : |
08.06.2007 |
IDENTIFICATION DETAILS
|
Name : |
UNITED PHARMACEUTICALS MANUFACTURING CO LTD |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2006 |
|
|
|
|
Date of Incorporation : |
08.06.1989 |
|
|
|
|
Com. Reg. No.: |
2161, |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Engaged in the manufacture of pharmaceutical preparations |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
US$ 400,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
SUMMARY
Company Name : UNITED PHARMACEUTICALS MANUFACTURING CO LTD
Country of Origin :
Legal Form : Limited Liability Company
Registration Date : 8th June 1989
Commercial Registration Number :
2161,
Issued Capital : JD 3,000,000
Paid up Capital : JD 3,000,000
Total Workforce : 230
Line of Business : Manufacturers of pharmaceutical preparations.
Financial Condition : Fair
Payments : Nothing detrimental uncovered
Operating Trend : Steady
COMPANY NAME
UNITED PHARMACEUTICALS MANUFACTURING CO LTD
ADDRESS
Registered & Physical Address
Street :
Area :
PO Box : 69
Town :
Country :
Telephone : (962-6) 4640771
Facsimile : (962-6) 4652386
Email : info@upm.com.jo
Premises
Subject operates from a medium sized suite of offices that are owned and located in the Central Business Area of Amman.
Branch Office (s)
Location Description
Al Raqeem Factory premises
Sahab
Tel : (962-6) 4162901
Fax : (962-6) 4162905
KEY PRINCIPALS
Munjid Munir Sukhtian Chairman
Nidal Munir Sukhtian Vice Chairman
Ghayyath Munir Sukhtian Director
Marlin Nicola Sukhtian Director
Rana Nidal Sukhtian Director
Dima Nidal Sukhtian Director
Dara Nidal Sukhtian Director
Onoud Nidal Sukhtian Director
Jamil Al Khateeb Finance Manager
Rashad Arafat Factory Manager
Mohamed Al Agbar Technical Manager
LEGAL FORM &
OWNERS
Date of Establishment : 8th June 1989
Legal Form : Sharikat Thet Massouliya Mahdoudeh (Limited Liability Company)
Commercial Reg. No. :
2161,
Issued Capital : JD 3,000,000
Paid up Capital : JD 3,000,000
Name of Shareholder
(s) Percentage
Munjid Munir Sukhtian 33.3%
Ghayyath Munir Sukhtian 33.3%
Nidal Munir Sukhtian 5.5%
Marlin Nicola Sukhtian 5.5%
Rana Nidal Sukhtian 5.5%
Dima Nidal Sukhtian 5.5%
Dara Nidal Sukhtian 5.5%
Onoud Nidal Sukhtian 5.5%
Note to the Legal Form A Limited Liability Company is defined in the Company Law as a company incorporated with a minimum of two and maximum of fifty shareholders, each responsible only for the liabilities of the company to the extent of their share participation in the capital of the company.
LINE OF BUSINESS
Operations :
Engaged in the manufacture of pharmaceutical preparations.
Import Countries :
International Suppliers :
Astra
Hiba Drugstore
U Carbon
Operating Trend : Steady
Subject has a workforce of 230 employees.
FINANCIAL HIGHLIGHTS
Financial highlights provided by outside sources are given below :
Currency : Jordanian Dinars (JD)
Year Ending 31/12/05 : Year Ending 31/12/06 :
Total Revenue JD 10,416,137 JD 10,628,711
Total Assets JD 8,191,193 JD 7,935,380
Stock JD 1,771,290 JD 1,912,993
Local sources consider subject’s financial condition to be Fair.
BANKERS
Arab Bank Plc
Shmeisani Branch
PO Box : 950545 & 950544
Tel : (962-6) 5607231 / 5607115
Fax : (962-6) 5606793 / 5606830
PAYMENT HISTORY
No complaints regarding subject’s payments have been reported.
GENERAL COMMENTS
Opinion on the credit figure of US$ 150,000:
Established in 1989, subject is owned and managed by members of the Sukhtian family who are well respected in the local business community.
Local sources report that payment obligations are met in a generally timely manner and the operating history is clear. As such the company is deemed a fair trade risk and the above credit figure is considered to be within subject’s financial means.
Maximum suggested credit figure: US$ 400,000
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)